Hormone replacement therapy is more prevalent among Jewish BRCA1/2 mutation carriers
Open Access
- 31 March 2006
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 42 (5) , 650-655
- https://doi.org/10.1016/j.ejca.2005.08.045
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Breast cancer and hormone-replacement therapy in the Million Women StudyThe Lancet, 2003
- Hormone replacement therapy regimens and breast cancer riskObstetrics & Gynecology, 2002
- Combined hormone replacement therapy and risk of breast cancer in a French cohort study of 3175 womenClimacteric, 2002
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Oral Contraceptives and CancerDrug Safety, 2001
- Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2The Lancet, 1999
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesAmerican Journal of Human Genetics, 1998
- Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studiesPublished by Elsevier ,1996
- The role of reproductive and menstrual factors in cancer of the breast before and after MenopauseEuropean Journal Of Cancer, 1996
- Oral contraceptives and breast cancer risk in DenmarkEuropean Journal Of Cancer, 1992